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Abstract
Introduction: Familial Mediterranean fever is an autosomal recessive disease that predominantly affects people of
the Mediterranean coast. One of the most frequent complications of the disease is amyloidosis. This clinical entity
is known as secondary (also called AA) amyloidosis.
Case presentation: In this report, we describe the case of a 33-year-old Turkish man with familial Mediterranean
fever and chronic renal insufficiency. He was admitted to our clinic with symptoms of suprarenal insufficiency. The
patient died three months later as a result of cardiac arrest.
Conclusion: Our aim is to make a contribution to the literature by reporting a case of combined insufficiency due
to the accumulation of renal and adrenal amyloid in a patient with familial Mediterranean fever, which has very
rarely been described in the literature. We hope that adrenal insufficiency, which becomes fatal if not diagnosed
and treated rapidly, will come to mind as easily as chronic renal failure in clinical practice.
Introduction
Familial Mediterranean fever (FMF) is an autoinflamma-
tory inherited autosomal recessive disease observed
especially in Jewish, Arabian, Armenian, and Turkish
communities [1]. FMF occurs as a result of mutations in
the Mediterranean fever (MEFV) gene. The MEFV gene
resides on the 16th chromosome. More than 75 muta-
tions associated with FMF have been found. Pyrin (or
marenostrin), the protein expressed by the MEFV gene,
is basically observed in myelomonocytic cells [2].
The development of renal amyloid is observed during
early childhood in the vast majority of patients with
FMF and is associated with symptoms such as fever,
abdominal pain, and inflammation attacks. Those
patients are grouped as phenotype I. However, in some
cases, renal amyloid is seen in older children (in the 13-
to 15-year-old age group) before the emergence of FMF
symptoms. These patients stay asymptomatic until the
formation of renal amyloidosis and are classified as phe-
notype II [3].
Addison’s disease is the primary disease of the adrenal
glands and is characterized by defects in the secretion of
mineralocorticoid and glucocorticoid hormones. The
most common cause of Addison’s disease is autoim-
mune or granulomatous destruction of the adrenal
glands [4].
FMF is an inherited inflammatory disease character-
ized by recurrent episodes of fever and polyserositis. AA
amyloidosis (secondary amyloidosis), which is specific to
FMF, predominantly develops in the kidneys and is
characterized by the existence of proteinuria. If left
untreated, reactive amyloidosis, the most devastating
complication of FMF, may lead to chronic renal failure.
Daily treatment with colchicine can prevent both the
FMF attacks and amyloid deposition. The effects of
FMF on the endocrine system are unclear. However,
thyroid and testicular abnormalities secondary to amy-
loidosis have been reported in patients with FMF [5,6].
AA type amyloid accumulation due to FMF affects the
gastrointestinal system and causes malabsorption of
food nutrients, which leads to stubborn diarrhea. Since
the liver and spleen are often affected, hepatosplenome-
galy is observed. Restrictive cardiomyopathy, congestive
heart failure, and arrhythmias may occur as a result of
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cardiac involvement [7]. Addison’s disease caused by
amyloid infiltration in the adrenal glands and azoosper-
mia and infertility due to the accumulation of amyloid
in the testes are observed.
Case presentation
A 33-year-old Turkish man was admitted to our emer-
gency department with complaints of nausea, vomiting,
weakness, diarrhea, and fever up to 38.8°C which had
lasted for one month. The patient, who had been diag-
nosed with FMF at 17 years of age, had been started on
a regular hemodialysis program at 29 years of age upon
the development of chronic renal failure due to amyloi-
dosis. He was not taking any pills regularly except col-
chicine tablets.
At his physical examination, his general appearance
was apathic and cachectic, his mucous membranes were
dry and pale, and his skin was dry and rough with a
urochromic color. His blood pressure was 110/70
mmHg, and his heart rate was 81 beats/minute. His
heartbeat was rhythmic with auscultation, and there was
no additional sound murmur. His abdominal examina-
tion showed that his liver extended 5 cm below the
costal margin. The hepatic surface was rough and even
and was painless on palpation. Traube’s space was
closed, and the spleen extended 2 cm below the costal
margin. His muscles were atrophied at the extremities,
and he had shedding hairs and an arteriovenous fistula
on the left arm. No other pathological findings were
detected during his systemic examinations.
At the time of his first admission to the hospital, his
laboratory tests with abnormal values were hemoglobin
9.2 g/dL, hematocrit 26.9%, mean corpuscular volume
79fL, creatinine 8.3 mg/dL, urea 60 mg/dL, albumin 2.1
mg/dL, sodium 132 mmol/L, International Normalized
Ratio 1.30, and prothrombin time 15.6 seconds. Hemo-
culture, stool microscopy, and stool culture were carried
out after we observed recurring high fever attacks dur-
ing his regular hemodialysis sessions, but he did not
have high fever at his follow-up examinations. When no
pathogenic microorganisms were detected, intravenous
ceftriaxone 1 g twice daily was started empirically. Dop-
pler ultrasonography and echocardiography were per-
formed to identify fistulas, but there was still no obvious
explanation for his fever.
After a fever that persisted for more than five days,
the patient was started on 1 g of intravenous vancomy-
cin once every four days. Abdominal ultrasonography
was performed, and hepatosplenomegaly was detected.
The liver edge was regular with hepatic parenchyma and
showed no pathological finding. His ductus choledochus
(common bile duct), intra-hepatic bile ducts, and gall-
bladder were all normal. Minimal ascites was detected
in the abdomen. Examination of the ascites puncture
sample produced no findings in favor of tuberculosis.
The patient was scheduled for gastroscopy and colono-
scopy but had hypoglycemic attacks during the prepara-
tion phase. His esophagogastroscopic examination
results were within normal ranges. Examination of rectal
biopsy samples taken during colonoscopy revealed type
AA amyloidosis.
The patient’s fever was closely monitored for hypogly-
cemic episodes and decreased as a result of two weeks
of antibiotic therapy. His ocular fundus examination and
cranial MRI scans were normal, but he kept on vomiting
frequently. During an attack of hypoglycemia, his labora-
tory results were blood glucose 36 mg/dL, insulin 0.2
μU/mL, C peptide 1.4 ng/mL, sodium 127 mmol/L, and
cortisol 7.68 mcg/dL. A Synacthen stimulation test was
planned with consultation by an endocrinologist to
investigate for adrenal insufficiency. The maximum cor-
tisol value measured was 8.87 μg/dL, and the patient
was diagnosed with adrenal insufficiency, so he was
started on prednisolone 40 mg per day administered
intramuscularly. Subsequently, prednisolone tablets 10
mg/day were started. The patient’s diarrhea came to an
end, and his hypoglycemia did not recur. The patient’s
complaints of fatigue and loss of appetite decreased. He
was discharged from the hospital with scheduled out-
patient clinic monitoring. Three months later he died in
the emergency department as a result of cardiac arrest
caused by hypokalemia.
Discussion
FMF is an autoinflammatory autosomal recessive inher-
ited disease and is relatively common in Jewish, Arabian,
and Turkish communities. There are usually some diffi-
culties in diagnosing the disease, which generally mani-
fests as fever and abdominal pain attacks due to
polyserositis. The disease is often confused with acute
appendicitis in patients with abdominal pain. Unneces-
sary appendectomies performed in these patients repre-
sent an important problem. To correctly diagnose the
disease, family history, biochemical tests, clinical presen-
tation, and response to colchicine are important. Despite
the fact that the Tel Hashomer criteria used for diagno-
sis do not have the genetic diagnosis title, genetic testing
is an important part of the diagnosis today. An MEFV
gene mutation determination is an auxiliary test for
making the diagnosis. Genetic diagnosis is important for
patients with type II FMF, especially those with an aty-
pical presentation. However in routine clinical practice,
a genetically based diagnosis may not be possible for all
patients, since only the 12 most common mutations are
checked.
The most significant and frequent complication of
FMF is chronic renal deficiency due to the accumulation
of renal amyloid. However, the accumulation of amyloid
Toros et al. Journal of Medical Case Reports 2011, 5:390
http://www.jmedicalcasereports.com/content/5/1/390
Page 2 of 3
may in fact occur in all kinds of organs and tissues.
Although the most common types of amyloid are AA,
amyloid light chain amyloidosis, and amyloidosis trans-
thyretin type, particularly AA-type amyloid deposition is
seen in patients with FMF. Accumulation of amyloid in
the adrenal glands is a rare condition. Also, in clinical
practice, it is important to recognize that the most com-
mon causes of Addison’s disease are granulomatous dis-
eases such as tuberculosis and autoimmunity [8].
Adrenal amyloid accumulation that manifests in the
form of Addison’s disease leads to nonspecific symp-
toms. Severe hypotension, sodium loss, hyperkalemia,
and hypoglycemia occur. To make the diagnosis, ran-
dom cortisol level assessments and an adrenocorticotro-
pic hormone stimulation test are used. To rule out the
most common factors, antibody level measurement and
imaging techniques are used. It is very important to
start corticosteroid replacement therapy immediately
after Addison’s disease is diagnosed.
As for the symptoms of FMF, daily colchicine treat-
ment can reduce the frequency of polyserositis episodes
occurring with abdominal pain and prevent amyloid
deposition. For patients who are unresponsive to colchi-
cine treatment, interferon a or thalidomide can be
applied as alternative forms of treatment [9].
Although amyloid often deposits in the kidneys, it can
be seen in any other organ or tissue [10]. Since our
patient had FMF with an atypical presentation and was
diagnosed late, he was started on colchicine treatment
in his early adulthood. Hence, he developed chronic
renal failure shortly afterward and had to undergo regu-
lar hemodialysis. AA amyloid deposited in his kidneys as
well as in his adrenal glands, hence triggering an adrenal
crisis, which is quite rare in patients with FMF. When
the patient was started on corticosteroid replacement
therapy, his diarrhea rapidly disappeared, his fatigue
decreased, and his episodes of hypoglycemia ended.
Conclusion
In the present report, we have tried to make a contribu-
tion to the literature by describing the case of a patient
with combined insufficiency in FMF due to the accumu-
lation of renal and adrenal amyloid, which has very
rarely been reported previously. We hope that adrenal
insufficiency, which becomes fatal if not diagnosed and
treated rapidly, will come to mind as easily as chronic
renal failure in clinical practice.
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